United Capital Financial Advisors’s Evoke Pharma EVOK Stock Holding History

United Capital Financial Advisors’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-97	Closed	-$26K	–	1234
2021 Q1	$26K	Hold	97	–	–	﹤0.01%	1176
2020 Q4	$36K	Hold	97	–	–	﹤0.01%	1176
2020 Q3	$66K	Sell	97 -11	-10%	-$7.02K	﹤0.01%	1124
2020 Q2	$55K	Hold	108	–	–	﹤0.01%	1163
2020 Q1	$18K	Hold	108	–	–	﹤0.01%	1167
2019 Q4	$25K	Hold	108	–	–	﹤0.01%	1351
2019 Q3	$13K	Hold	108	–	–	﹤0.01%	1293
2019 Q2	$10K	Hold	108	–	–	﹤0.01%	1458
2019 Q1	$23K	Hold	108	–	–	﹤0.01%	1339
2018 Q4	$39K	Hold	108	–	–	﹤0.01%	1261
2018 Q3	$46K	Hold	108	–	–	﹤0.01%	1311
2018 Q2	$39K	Hold	108	–	–	﹤0.01%	1288
2018 Q1	$32K	Hold	108	–	–	﹤0.01%	1290
2017 Q4	$35K	Hold	108	–	–	﹤0.01%	1289
2017 Q3	$52K	Hold	108	–	–	﹤0.01%	1290
2017 Q2	$40K	Buy	+108	New	+$41.4K	﹤0.01%	1262

Other funds holding EVOK

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

United Capital Financial Advisors's EVOK Position: Q2 2021 in Review

United Capital Financial Advisors sold out of Evoke Pharma (EVOK) in Q2 2021, closing a stake of 97 shares — an estimated $26K sold.

United Capital Financial Advisors first reported a position in EVOK in Q2 2017 and held it in 16 quarters. The position peaked at $66K in Q3 2020. 19 funds tracked by Wall St. Rank hold EVOK as of Q2 2021.

United Capital Financial Advisors reported no remaining Evoke Pharma position as of Q2 2021 after selling out during the quarter.
United Capital Financial Advisors sold 97 Evoke Pharma shares in Q2 2021, an estimated $26K.
United Capital Financial Advisors first reported a position in Evoke Pharma in Q2 2017 and held it in 16 quarters.
United Capital Financial Advisors's Evoke Pharma position peaked at $66K in Q3 2020.
19 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2021.

Based on United Capital Financial Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.